Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
The company is progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102, targeting LRRK2 for neurodegenerative disorders; and ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma.
In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC® androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024.
#TeamArvinas is made up of approximately 450 passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC® protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.
Position Summary
As an important member of the Arvinas Market Access Team, the Director, Payer Accounts will be a key contributor to a strong National Accounts team. They will be responsible for driving profitable patient access with their designated national payer organizations, largest downstream regional account clients as well as their assigned state Medicaid payers. They will be a leader in cross-functional teams to ensure that payer coverage and formulary initiatives are properly understood and aligned with corporate strategies. The Director, Payer Accounts will work closely with Patient Services to ensure rapid and unobstructed access to Arvinas therapies for patients. This position plays a key role in collaborating with colleagues in market access, medical affairs, access strategy, field sales, marketing, and operations to align approaches to our largest customers. Supporting the strategy of the Market Access team the senior director will develop key relationships, present pre and post approval information, negotiate contracts, secure pharmacy policies that maximize patient access and ensure that the clinical and financial value of our products is fully understood.
This position reports to the Executive Director of Strategic & National Accounts and will be performed remotely from a location within the designated geography that the candidate will be responsible for developing.
Principal Responsibilities
Key responsibilities of this role include, but are not limited to:
Qualifications
Education
#LI-Remote
Arvinas is proud to offer a competitive package of base and incentive compensation as well as a comprehensive benefits program designed to support the health, wellness and financial security of our employees and their families. Benefits include group medical, vision and dental coverage, group and supplemental life insurance, and much more. To learn more about Arvinas, please visit www.arvinas.com
Arvinas is an Equal Opportunity Employer